BACKGROUND: Aortic dissection remains the most common aortic catastrophe. In the endovascular era, the management of acute type B aortic dissection (ATBAD) is undergoing dramatic changes. The aim of this study is to evaluate the long-term outcomes of patients with ATBAD who were treated at our center over a 13-year period. METHODS AND RESULTS: We reviewed patients with ATBAD between 2001 and 2014, analyzing variables based on status (complicated [c] versus uncomplicated [u]) and treatment modalities. We defined cATBAD as rupture, expansion of diameter on imaging during the admission, persistent pain, or clinical malperfusion leading to a deficit in cerebral, spinal, visceral, renal, or peripheral vascular territories at presentation or during initial hospitalization. Postoperative outcomes were defined as deficits not present before the intervention. Outcomes were compared between the groups by use of Kaplan-Meier and descriptive statistics. We treated 442 patients with ATBAD. Of those 442, 60.6% had uATBAD and were treated medically, and 39.4% had cATBAD, of whom 39.0% were treated medically to 30.0% with open repair, 21.3% with thoracic endovascular aortic repair, and 9.7% with other open peripheral procedures. Intervention-free survival at 1 and 5 years was 84.8% and 62.7% for uATBAD, 61.8% and 44.0% for cATBAD-medical, 69.2% and 47.2% for cATBAD-open, and 68.0% and 42.5% for cATBAD-thoracic endovascular aortic repair, respectively (P=0.001). Overall survival was significantly related primarily to complicated presentation. CONCLUSIONS: In our experience, early and late outcomes of ATBAD were dependent on the presence of complications, with cATBAD faring worse. Although uATBAD was associated with favorable early survival, late complications still occurred, mandating radiographic surveillance and open or endovascular interventions. Prospective trials are required to better determine the optimal therapy for uATBAD.
BACKGROUND: Aortic dissection remains the most common aortic catastrophe. In the endovascular era, the management of acute type B aortic dissection (ATBAD) is undergoing dramatic changes. The aim of this study is to evaluate the long-term outcomes of patients with ATBAD who were treated at our center over a 13-year period. METHODS AND RESULTS: We reviewed patients with ATBAD between 2001 and 2014, analyzing variables based on status (complicated [c] versus uncomplicated [u]) and treatment modalities. We defined cATBAD as rupture, expansion of diameter on imaging during the admission, persistent pain, or clinical malperfusion leading to a deficit in cerebral, spinal, visceral, renal, or peripheral vascular territories at presentation or during initial hospitalization. Postoperative outcomes were defined as deficits not present before the intervention. Outcomes were compared between the groups by use of Kaplan-Meier and descriptive statistics. We treated 442 patients with ATBAD. Of those 442, 60.6% had uATBAD and were treated medically, and 39.4% had cATBAD, of whom 39.0% were treated medically to 30.0% with open repair, 21.3% with thoracic endovascular aortic repair, and 9.7% with other open peripheral procedures. Intervention-free survival at 1 and 5 years was 84.8% and 62.7% for uATBAD, 61.8% and 44.0% for cATBAD-medical, 69.2% and 47.2% for cATBAD-open, and 68.0% and 42.5% for cATBAD-thoracic endovascular aortic repair, respectively (P=0.001). Overall survival was significantly related primarily to complicated presentation. CONCLUSIONS: In our experience, early and late outcomes of ATBAD were dependent on the presence of complications, with cATBAD faring worse. Although uATBAD was associated with favorable early survival, late complications still occurred, mandating radiographic surveillance and open or endovascular interventions. Prospective trials are required to better determine the optimal therapy for uATBAD.
Authors: Anthony L Estrera; Charles C Miller; Jennifer Goodrick; Eyal E Porat; Paul E Achouh; Jayesh Dhareshwar; Riad Meada; Ali Azizzadeh; Hazim J Safi Journal: Ann Thorac Surg Date: 2007-02 Impact factor: 4.330
Authors: Christoph A Nienaber; Stephan Kische; Hervé Rousseau; Holger Eggebrecht; Tim C Rehders; Guenther Kundt; Aenne Glass; Dierk Scheinert; Martin Czerny; Tilo Kleinfeldt; Burkhart Zipfel; Louis Labrousse; Rossella Fattori; Hüseyin Ince Journal: Circ Cardiovasc Interv Date: 2013-08-06 Impact factor: 6.546
Authors: J Brunkwall; P Kasprzak; E Verhoeven; R Heijmen; P Taylor; P Alric; L Canaud; M Janotta; D Raithel; W Malina; Ti Resch; H-H Eckstein; S Ockert; T Larzon; F Carlsson; H Schumacher; S Classen; P Schaub; J Lammer; L Lönn; R E Clough; V Rampoldi; S Trimarchi; J-N Fabiani; D Böckler; D Kotelis; D Böckler; D Kotelis; H von Tenng-Kobligk; N Mangialardi; S Ronchey; G Dialetto; V Matoussevitch Journal: Eur J Vasc Endovasc Surg Date: 2014-06-22 Impact factor: 7.069
Authors: Jennifer M Hanna; Nicholas D Andersen; Asvin M Ganapathi; Richard L McCann; G Chad Hughes Journal: J Vasc Surg Date: 2013-10-01 Impact factor: 4.268
Authors: Rossella Fattori; Thomas T Tsai; Truls Myrmel; Arturo Evangelista; Jeanna V Cooper; Santi Trimarchi; Jin Li; Luigi Lovato; Stephan Kische; Kim A Eagle; Eric M Isselbacher; Christoph A Nienaber Journal: JACC Cardiovasc Interv Date: 2008-08 Impact factor: 11.195
Authors: Anna M Sailer; Patricia J Nelemans; Trevor J Hastie; Anne S Chin; Mark Huininga; Peter Chiu; Michael P Fischbein; Michael D Dake; D Craig Miller; G W Schurink; Dominik Fleischmann Journal: J Thorac Cardiovasc Surg Date: 2017-05-16 Impact factor: 5.209
Authors: Anna M Sailer; Sander M J van Kuijk; Patricia J Nelemans; Anne S Chin; Aya Kino; Mark Huininga; Johanna Schmidt; Gabriel Mistelbauer; Kathrin Bäumler; Peter Chiu; Michael P Fischbein; Michael D Dake; D Craig Miller; Geert Willem H Schurink; Dominik Fleischmann Journal: Circ Cardiovasc Imaging Date: 2017-04 Impact factor: 7.792
Authors: Gino Gialdini; Neal S Parikh; Abhinaba Chatterjee; Michael P Lerario; Hooman Kamel; Darren B Schneider; Babak B Navi; Santosh B Murthy; Costantino Iadecola; Alexander E Merkler Journal: Stroke Date: 2017-06-27 Impact factor: 7.914
Authors: Xiaoying Lou; Yazan M Duwayri; Edward P Chen; William D Jordan; Jessica Forcillo; Carl A Zehner; Bradley G Leshnower Journal: Ann Thorac Surg Date: 2018-10-04 Impact factor: 4.330